Pluri PLUR
NASDAQ PLUR
$1.71 -0.05 (-2.84%)
As of: Aug 21, 2026 · 3:59 PM EDT

Pluri (PLUR) Change in Accured Expenses (2010 - 2025)

Pluri (PLUR) posted quarterly Change in Accured Expenses of $903000.0 for Q4 2025, up 157.63% year-over-year from $350508.1 in Q4 2024, and up 320.24% quarter-over-quarter from -$410000.0 in Q3 2025.

Pluri (PLUR) Change in Accured Expenses (2010 - 2025) Analysis & Trends

Pluri (PLUR) has reported Change in Accured Expenses for 16 consecutive years, with $903000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Change in Accured Expenses rose 157.63% year-over-year to $903000.0; the TTM figure through Dec 2025 stood at $1.1 million (up 179.35% YoY), while the FY2025 annual figure was $377000.0, up 231.36% from the prior year.
  • Change in Accured Expenses grew to $903000.0 in Q4 2025 per PLUR's latest filing, from -$410000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.4 million in Q2 2021 and bottomed at -$3.0 million in Q2 2022.
  • Historically, Change in Accured Expenses has averaged -$109950.0 across 5 years, with a median of -$27000.0 in 2022.
  • Annual changes were most pronounced in 2021 — Change in Accured Expenses slumped 1775.0% — and 2023, when it soared 2172.22%.
  • Pluri's Change in Accured Expenses stood at -$1.3 million in 2021, then surged by 104.03% to $54000.0 in 2022, then jumped by 2172.22% to $1.2 million in 2023, then tumbled by 227.71% to -$1.6 million in 2024, then soared by 157.63% to $903000.0 in 2025.
  • Business Quant data shows PLUR's Change in Accured Expenses at $903000.0 in Q4 2025, -$410000.0 in Q3 2025, and -$544000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 212.44 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 61.62 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 68.82 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Pluri 16.21 Mn 3.72 Mn 86,000.00 -177,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 903,000.00
Dec 31, 2025 903,000.00
Sep 30, 2025 -410,000.00
Sep 30, 2025 -410,000.00
Jun 30, 2025 -544,000.00
Jun 30, 2025 -544,000.00
Mar 31, 2025 1.15 Mn
Mar 31, 2025 1.15 Mn
Dec 31, 2024 -1.57 Mn
Dec 31, 2024 -1.57 Mn
Sep 30, 2024 1.34 Mn
Sep 30, 2024 1.34 Mn
Jun 30, 2024 168,000.00
Jun 30, 2024 168,000.00
Mar 31, 2024 -1.32 Mn
Mar 31, 2024 -1.32 Mn
Dec 31, 2023 1.23 Mn
Dec 31, 2023 1.23 Mn
Sep 30, 2023 -358,000.00
Sep 30, 2023 -358,000.00